EMEA (Europe, Middle East and Africa) Prostate Cancer Drugs Market Report 2018

EMEA (Europe, Middle East and Africa) Prostate Cancer Drugs Market Report 2018

1 Prostate Cancer Drugs Overview

1.1 Product Overview and Scope of Prostate Cancer Drugs

1.2 Classification of Prostate Cancer Drugs

1.2.1 EMEA Prostate Cancer Drugs Market Size (Sales) Comparison by Type (2013-2025)

1.2.2 EMEA Prostate Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 Hormonal Therapy

1.2.4 Chemotherapy

1.2.5 Immunotherapy

1.2.6 Targeted Therapy

1.3 EMEA Prostate Cancer Drugs Market by Application/End Users

1.3.1 EMEA Prostate Cancer Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Other

1.4 EMEA Prostate Cancer Drugs Market by Region

1.4.1 EMEA Prostate Cancer Drugs Market Size (Value) Comparison by Region (2013-2025)

1.4.2 Europe Status and Prospect (2013-2025)

1.4.3 Middle East Status and Prospect (2013-2025)

1.4.4 Africa Status and Prospect (2013-2025)

1.5 EMEA Market Size (Value and Volume) of Prostate Cancer Drugs (2013-2025)

1.5.1 EMEA Prostate Cancer Drugs Sales and Growth Rate (2013-2025)

1.5.2 EMEA Prostate Cancer Drugs Revenue and Growth Rate (2013-2025)

2 EMEA Prostate Cancer Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Prostate Cancer Drugs Market Competition by Players/Manufacturers

2.1.1 EMEA Prostate Cancer Drugs Sales Volume and Market Share of Major Players (2013-2018)

2.1.2 EMEA Prostate Cancer Drugs Revenue and Share by Players (2013-2018)

2.1.3 EMEA Prostate Cancer Drugs Sale Price by Players (2013-2018)

2.2 EMEA Prostate Cancer Drugs (Volume and Value) by Type/Product Category

2.2.1 EMEA Prostate Cancer Drugs Sales and Market Share by Type (2013-2018)

2.2.2 EMEA Prostate Cancer Drugs Revenue and Market Share by Type (2013-2018)

2.2.3 EMEA Prostate Cancer Drugs Sale Price by Type (2013-2018)

2.3 EMEA Prostate Cancer Drugs (Volume) by Application

2.4 EMEA Prostate Cancer Drugs (Volume and Value) by Region

2.4.1 EMEA Prostate Cancer Drugs Sales and Market Share by Region (2013-2018)

2.4.2 EMEA Prostate Cancer Drugs Revenue and Market Share by Region (2013-2018)

2.4.3 EMEA Prostate Cancer Drugs Sales Price by Region (2013-2018)

3 Europe Prostate Cancer Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Prostate Cancer Drugs Sales and Value (2013-2018)

3.1.1 Europe Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)

3.1.2 Europe Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)

3.2 Europe Prostate Cancer Drugs Sales and Market Share by Type

3.3 Europe Prostate Cancer Drugs Sales and Market Share by Application

3.4 Europe Prostate Cancer Drugs Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Prostate Cancer Drugs Sales Volume by Countries (2013-2018)

3.4.2 Europe Prostate Cancer Drugs Revenue by Countries (2013-2018)

3.4.3 Germany Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

3.4.4 France Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

3.4.5 UK Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

3.4.6 Russia Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

3.4.7 Italy Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

3.4.8 Benelux Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

4 Middle East Prostate Cancer Drugs (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Prostate Cancer Drugs Sales and Value (2013-2018)

4.1.1 Middle East Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)

4.1.2 Middle East Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)

4.2 Middle East Prostate Cancer Drugs Sales and Market Share by Type

4.3 Middle East Prostate Cancer Drugs Sales and Market Share by Application

4.4 Middle East Prostate Cancer Drugs Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Prostate Cancer Drugs Sales Volume by Countries (2013-2018)

4.4.2 Middle East Prostate Cancer Drugs Revenue by Countries (2013-2018)

4.4.3 Saudi Arabia Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

4.4.4 Israel Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

4.4.5 UAE Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

4.4.6 Iran Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

5 Africa Prostate Cancer Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Prostate Cancer Drugs Sales and Value (2013-2018)

5.1.1 Africa Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)

5.1.2 Africa Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)

5.2 Africa Prostate Cancer Drugs Sales and Market Share by Type

5.3 Africa Prostate Cancer Drugs Sales and Market Share by Application

5.4 Africa Prostate Cancer Drugs Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Prostate Cancer Drugs Sales Volume by Countries (2013-2018)

5.4.2 Africa Prostate Cancer Drugs Revenue by Countries (2013-2018)

5.4.3 South Africa Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

5.4.4 Nigeria Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

5.4.5 Egypt Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

5.4.6 Algeria Prostate Cancer Drugs Sales and Growth Rate (2013-2018)

6 EMEA Prostate Cancer Drugs Manufacturers/Players Profiles and Sales Data

6.1 AbbVie

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Prostate Cancer Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Astellas Pharma

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Prostate Cancer Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Astra Zeneca

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Prostate Cancer Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Johnson & Johnson

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Prostate Cancer Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Sanofi

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Prostate Cancer Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 GlaxoSmithKline

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Prostate Cancer Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Merck Group

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Prostate Cancer Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Novartis

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Prostate Cancer Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Amgen

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Prostate Cancer Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Bayer HealthCare

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Prostate Cancer Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 Ferring Pharmaceutical

6.12 Janssen Pharmaceuticals

6.13 Endo Pharmaceuticals

6.14 BMS

6.15 Takeda Pharmaceuticals

6.16 Northwest Biotherapeutics

6.17 Teva Pharmaceutical

6.18 Boehringer Ingelheim

6.19 Foresee Pharmaceuticals

6.20 Tokai Pharmaceuticals

6.21 Spectrum Pharmaceuticals

7 Prostate Cancer Drugs Manufacturing Cost Analysis

7.1 Prostate Cancer Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Prostate Cancer Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Prostate Cancer Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Prostate Cancer Drugs Market Forecast (2018-2025)

11.1 EMEA Prostate Cancer Drugs Sales, Revenue and Price Forecast (2018-2025)

11.1.1 EMEA Prostate Cancer Drugs Sales and Growth Rate Forecast (2018-2025)

11.1.2 EMEA Prostate Cancer Drugs Revenue and Growth Rate Forecast (2018-2025)

11.1.3 EMEA Prostate Cancer Drugs Price and Trend Forecast (2018-2025)

11.2 EMEA Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.3 Europe Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.4 Middle Eastt Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.5 Africa Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.6 EMEA Prostate Cancer Drugs Sales Forecast by Type (2018-2025)

11.7 EMEA Prostate Cancer Drugs Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Prostate Cancer Drugs

Figure EMEA Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2025)

Figure EMEA Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2017

Figure Hormonal Therapy Product Picture

Figure Chemotherapy Product Picture

Figure Immunotherapy Product Picture

Figure Targeted Therapy Product Picture

Figure EMEA Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2013-2025)

Figure EMEA Sales Market Share of Prostate Cancer Drugs by Application in 2017

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Other Examples

Table Key Downstream Customer in Other

Figure EMEA Prostate Cancer Drugs Market Size (Million USD) by Region (2013-2025)

Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Prostate Cancer Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Middle East Prostate Cancer Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Africa Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Africa Prostate Cancer Drugs Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2025)

Figure EMEA Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure EMEA Prostate Cancer Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)

Table EMEA Prostate Cancer Drugs Sales Volume (K Pcs) of Major Players (2013-2018)

Table EMEA Prostate Cancer Drugs Sales Share by Players (2013-2018)

Figure 2017 Prostate Cancer Drugs Sales Share by Players

Figure 2017 Prostate Cancer Drugs Sales Share by Players

Figure EMEA Prostate Cancer Drugs Market Major Players Product Revenue (Million USD) (2013-2018)

Table EMEA Prostate Cancer Drugs Revenue (Million USD) by Players (2013-2018)

Table EMEA Prostate Cancer Drugs Revenue Share by Players (2013-2018)

Table 2017 EMEA Prostate Cancer Drugs Revenue Share by Players

Table 2017 EMEA Prostate Cancer Drugs Revenue Share by Players

Table EMEA Prostate Cancer Drugs Sale Price (USD/Pcs) by Players (2013-2018)

Table EMEA Prostate Cancer Drugs Sales (K Pcs) and Market Share by Type (2013-2018)

Table EMEA Prostate Cancer Drugs Sales Share by Type (2013-2018)

Figure Sales Market Share of Prostate Cancer Drugs by Type (2013-2018)

Figure EMEA Prostate Cancer Drugs Sales Market Share by Type (2013-2018)

Table EMEA Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018)

Table EMEA Prostate Cancer Drugs Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Prostate Cancer Drugs by Type in 2017

Table EMEA Prostate Cancer Drugs Sale Price (USD/Pcs) by Type (2013-2018)

Table EMEA Prostate Cancer Drugs Sales (K Pcs) and Market Share by Application (2013-2018)

Table EMEA Prostate Cancer Drugs Sales Share by Application (2013-2018)

Figure Sales Market Share of Prostate Cancer Drugs by Application (2013-2018)

Figure EMEA Prostate Cancer Drugs Sales Market Share by Application in 2017

Table EMEA Prostate Cancer Drugs Sales (K Pcs) and Market Share by Region (2013-2018)

Table EMEA Prostate Cancer Drugs Sales Share by Region (2013-2018)

Figure Sales Market Share of Prostate Cancer Drugs by Region (2013-2018)

Figure EMEA Prostate Cancer Drugs Sales Market Share in 2017

Table EMEA Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)

Table EMEA Prostate Cancer Drugs Revenue Share by Region (2013-2018)

Figure Revenue Market Share of Prostate Cancer Drugs by Region (2013-2018)

Figure EMEA Prostate Cancer Drugs Revenue Market Share Regions in 2017

Table EMEA Prostate Cancer Drugs Sales Price (USD/Pcs) by Region (2013-2018)

Figure Europe Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Drugs Sales (K Pcs) by Type (2013-2018)

Table Europe Prostate Cancer Drugs Market Share by Type (2013-2018)

Figure Europe Prostate Cancer Drugs Market Share by Type in 2017

Table Europe Prostate Cancer Drugs Sales (K Pcs) by Application (2013-2018)

Table Europe Prostate Cancer Drugs Market Share by Application (2013-2018)

Figure Europe Prostate Cancer Drugs Market Share by Application in 2017

Table Europe Prostate Cancer Drugs Sales (K Pcs) by Countries (2013-2018)

Table Europe Prostate Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Drugs Sales Market Share by Countries in 2017

Table Europe Prostate Cancer Drugs Revenue (Million USD) by Countries (2013-2018)

Table Europe Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Drugs Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure France Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure UK Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Benelux Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Middle East Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Middle East Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)

Table Middle East Prostate Cancer Drugs Sales (K Pcs) by Type (2013-2018)

Table Middle East Prostate Cancer Drugs Market Share by Type (2013-2018)

Figure Middle East Prostate Cancer Drugs Market Share by Type (2013-2018)

Table Middle East Prostate Cancer Drugs Sales (K Pcs) by Applications (2013-2018)

Table Middle East Prostate Cancer Drugs Market Share by Applications (2013-2018)

Figure Middle East Prostate Cancer Drugs Sales Market Share by Application in 2017

Table Middle East Prostate Cancer Drugs Sales Volume (K Pcs) by Countries (2013-2018)

Table Middle East Prostate Cancer Drugs Sales Volume Market Share by Countries (2013-2018)

Figure Middle East Prostate Cancer Drugs Sales Volume Market Share by Countries in 2017

Table Middle East Prostate Cancer Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East Prostate Cancer Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Israel Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Iran Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Africa Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Africa Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)

Table Africa Prostate Cancer Drugs Sales (K Pcs) by Type (2013-2018)

Table Africa Prostate Cancer Drugs Sales Market Share by Type (2013-2018)

Figure Africa Prostate Cancer Drugs Sales Market Share by Type (2013-2018)

Figure Africa Prostate Cancer Drugs Sales Market Share by Type in 2017

Table Africa Prostate Cancer Drugs Sales (K Pcs) by Application (2013-2018)

Table Africa Prostate Cancer Drugs Sales Market Share by Application (2013-2018)

Figure Africa Prostate Cancer Drugs Sales Market Share by Application (2013-2018)

Table Africa Prostate Cancer Drugs Sales Volume (K Pcs) by Countries (2013-2018)

Table Africa Prostate Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Africa Prostate Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Africa Prostate Cancer Drugs Sales Market Share by Countries in 2017

Table Africa Prostate Cancer Drugs Revenue (Million USD) by Countries (2013-2018)

Table Africa Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Africa Prostate Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Africa Prostate Cancer Drugs Revenue Market Share by Countries in 2017

Figure South Africa Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Algeria Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Table AbbVie Prostate Cancer Drugs Basic Information List

Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure AbbVie Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure AbbVie Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure AbbVie Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Astellas Pharma Prostate Cancer Drugs Basic Information List

Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Astellas Pharma Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Astellas Pharma Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Astra Zeneca Prostate Cancer Drugs Basic Information List

Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Astra Zeneca Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Astra Zeneca Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Johnson & Johnson Prostate Cancer Drugs Basic Information List

Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Johnson & Johnson Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Sanofi Prostate Cancer Drugs Basic Information List

Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Sanofi Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Sanofi Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Sanofi Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table GlaxoSmithKline Prostate Cancer Drugs Basic Information List

Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure GlaxoSmithKline Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Merck Group Prostate Cancer Drugs Basic Information List

Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Merck Group Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Merck Group Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Merck Group Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Novartis Prostate Cancer Drugs Basic Information List

Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Novartis Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Novartis Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Novartis Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Amgen Prostate Cancer Drugs Basic Information List

Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Amgen Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Amgen Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Amgen Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Bayer HealthCare Prostate Cancer Drugs Basic Information List

Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)

Figure Bayer HealthCare Prostate Cancer Drugs Sales Market Share in EMEA (2013-2018)

Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share in EMEA (2013-2018)

Table Ferring Pharmaceutical Prostate Cancer Drugs Basic Information List

Table Janssen Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table Endo Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table BMS Prostate Cancer Drugs Basic Information List

Table Takeda Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table Northwest Biotherapeutics Prostate Cancer Drugs Basic Information List

Table Teva Pharmaceutical Prostate Cancer Drugs Basic Information List

Table Boehringer Ingelheim Prostate Cancer Drugs Basic Information List

Table Foresee Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table Tokai Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table Spectrum Pharmaceuticals Prostate Cancer Drugs Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostate Cancer Drugs

Figure Manufacturing Process Analysis of Prostate Cancer Drugs

Figure Prostate Cancer Drugs Industrial Chain Analysis

Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017

Table Major Buyers of Prostate Cancer Drugs

Table Distributors/Traders List

Figure EMEA Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)

Figure EMEA Prostate Cancer Drugs Revenue and Growth Rate Forecast (2018-2025)

Figure EMEA Prostate Cancer Drugs Price (USD/Pcs) and Trend Forecast (2018-2025)

Table EMEA Prostate Cancer Drugs Sales (K Pcs) Forecast by Region (2018-2025)

Figure EMEA Prostate Cancer Drugs Sales Market Share Forecast by Region (2018-2025)

Table EMEA Prostate Cancer Drugs Revenue (Million USD) Forecast by Region (2018-2025)

Figure EMEA Prostate Cancer Drugs Revenue Market Share Forecast by Region (2018-2025)

Table Europe Prostate Cancer Drugs Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Europe Prostate Cancer Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Europe Prostate Cancer Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Europe Prostate Cancer Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table Middle East Prostate Cancer Drugs Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Middle East Prostate Cancer Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Middle East Prostate Cancer Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Middle East Prostate Cancer Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table Africa Prostate Cancer Drugs Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Africa Prostate Cancer Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Africa Prostate Cancer Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Africa Prostate Cancer Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table EMEA Prostate Cancer Drugs Sales (K Pcs) Forecast by Type (2018-2025)

Figure EMEA Prostate Cancer Drugs Sales Market Share Forecast by Type (2018-2025)

Table EMEA Prostate Cancer Drugs Sales (K Pcs) Forecast by Application (2018-2025)

Figure EMEA Prostate Cancer Drugs Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources